Overview
Dr. Patel joined SCRI in 2024, as director of lymphoma research, and oversees SCRI’s comprehensive lymphoma clinical trial portfolio. Previously, he served as the Director of Hematologic Malignancies and Cell Therapy at the Swedish Cancer Institute in Seattle, Washington, where he led development of the program’s clinical standards for lymphoma care, assisted in the expansion of cell therapy services, and helped shape lymphoma research efforts. Dr. Patel was also a member of the Paul G. Allen Research Center at Seattle Cancer Institute, serving as a co-founding member of the Center for Immuno-oncology, where he collaborated on translational research related to immunotherapy in hematologic diseases.
Dr. Patel has been published in various medical journals, including New England Journal of Medicine, Blood, and Journal of Clinical Oncology. He is also a member of the ASCO Cancer Communications Committee, the CIBMTR Lymphoma Working Committee, and the National Planning Committee for the Lymphoma Research Foundation Lymphoma Rounds. His clinical and research focus is in lymphomas, CLL, and cellular therapy.
Dr. Patel is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Dr. Patel is board certified in Internal Medicine, Hematology, and Medical Oncology. He is actively involved in clinical research, co-authoring 66 peer reviewed articles and participating in 5 clinical trials. Dr. Patel is currently accepting new patients.
Graduate Year
Residency
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Accepted plan types not found. Please verify directly with the provider.
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
335 24th Ave N Ste 200, Nashville, TN 37203
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Tennessee Oncology Pharmacy Dispensing
Ian Flinn is a Hematologist practicing medicine in Nashville, Tennessee. Dr. Flinn is highly rated in 43 conditions, according to our data. His clinical expertise encompasses Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Vanderbilt-Ingram Cancer Center
Brian Rini is a Hematologist practicing medicine in Nashville, Tennessee. Dr. Rini is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Prostatectomy.
Tennessee Oncology Pharmacy Dispensing
Jesus Berdeja is a Hematologist practicing medicine in Nashville, Tennessee. Dr. Berdeja is highly rated in 41 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Krish Patel
Is Dr. Krish Patel a top-rated expert for Mantle Cell Lymphoma (MCL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Krish Patel is classified as an Elite expert for Mantle Cell Lymphoma (MCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Krish Patel specialize in?
While Dr. Krish Patel is a Hematology, they have specific expertise in Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, and Follicular Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Krish Patel participate in research or clinical trials?
Yes. Dr. Krish Patel has published 66 articles and abstracts on conditions like Mantle Cell Lymphoma (MCL). You can view a list of Dr. Krish Patel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Krish Patel accept my insurance?
Dr. Krish Patel accepts most major insurance plans, including Aetna and Cambia Health Solutions. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Mantle Cell Lymphoma (MCL)
- Distinguished
- B-Cell LymphomaDr. Patel isDistinguished. Learn about B-Cell Lymphoma.
- Chronic Lymphocytic Leukemia (CLL)Dr. Patel isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Patel isDistinguished. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Follicular LymphomaDr. Patel isDistinguished. Learn about Follicular Lymphoma.
- Large-Cell Immunoblastic LymphomaDr. Patel isDistinguished. Learn about Large-Cell Immunoblastic Lymphoma.
- Non-Hodgkin LymphomaDr. Patel isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Advanced
- Anaplastic Large Cell LymphomaDr. Patel isAdvanced. Learn about Anaplastic Large Cell Lymphoma.
- Classical Hodgkin LymphomaDr. Patel isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Gastric LymphomaDr. Patel isAdvanced. Learn about Gastric Lymphoma.
- Hodgkin LymphomaDr. Patel isAdvanced. Learn about Hodgkin Lymphoma.
- Lung CancerDr. Patel isAdvanced. Learn about Lung Cancer.
- Marginal Zone Lymphoma (MZL)Dr. Patel isAdvanced. Learn about Marginal Zone Lymphoma (MZL).
- Experienced
- Adult Soft Tissue SarcomaDr. Patel isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Angioimmunoblastic T-cell LymphomaDr. Patel isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- Bone Marrow AspirationDr. Patel isExperienced. Learn about Bone Marrow Aspiration.
- Bone Marrow TransplantDr. Patel isExperienced. Learn about Bone Marrow Transplant.
- Colorectal CancerDr. Patel isExperienced. Learn about Colorectal Cancer.
- Cutaneous T-Cell Lymphoma (CTCL)Dr. Patel isExperienced. Learn about Cutaneous T-Cell Lymphoma (CTCL).